Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 March 2021 | Story Xolisa Mnukwa | Photo Sonia Small
UFS Division of Student Affairs launch On the Red Couch pocket guide for staff and a Universal Access Checklist encouraging a socially just student-life experience promoting academic success and all-inclusive student engagement.

In line with their operational mandate that seeks to humanise the lived experiences of students and implore an ethically just society within the University of the Free State (UFS) community, the Division of Student Affairs (DSA) has launched two publications – On the Red Couch: A pocket guide for staff and the Universal Access Checklist.

On the red couch: A pocket guide for staff

On the Red Couch was launched by the UFS Department of Student Counselling and Development (SCD) in support of student well-being. 

The purpose of this pocket guide is to equip staff with information, guidance, and skills to support students who are experiencing mental health distress and to enthuse well-being. The guide highlights a variety of services and tips that SCD educates staff about, ranging from group counselling, career counselling, recognising a student in distress, to enlightening them on how to respond to students in emergency situations.

“What mental health needs is more sunlight, more candor, and more unashamed conversation.” – Glenn Close

Universal Access Checklist

In their mission to develop an inclusive institutional culture that provides humanising experiences essential to the academic success and engagement of students, the UFS Centre for Universal Access and Disability Support (CUADS) has developed the Universal Access Checklist. 

This checklist is a comprehensive guide that propels academic and social spaces within the higher education environment to make online as well as face-to-face interactions and events accessible to both staff and students with disabilities. 

The checklist encourages universal design in the planning of events/ gatherings/ meetings and interaction within the university by providing clear guidelines on how the UFS society can effectively embrace all of its members, including being cognisant of the categories of disabilities in its environment, ranging from visual/mobility/hearing impairments to learning difficulties to mental health challenges. 

The checklist also covers subjects concerning accessible university accommodation, hosting events on various platforms, marketing material, food requirements, and preferred pronouns. 

“As a university, we host all kinds of events in person and virtually. It is imperative to ensure that we create opportunities for full participation of all people in order to realise the university’s ideal of an inclusive and socially just institutional culture,” says Mosa Moerane, CUADS Liaison, Advocacy and Awareness Officer.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept